These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17853318)

  • 1. Causes of redo procedures in patients with an implantable cardioverter-defibrillator--long-term follow-up results.
    Gepner K; Przybylski A; Maciag A; Sterliński M; Lewandowski M; Syska P; Kowalik I; Szwed H
    Kardiol Pol; 2007 Aug; 65(8):893-8; discussion 899. PubMed ID: 17853318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management.
    Eckstein J; Koller MT; Zabel M; Kalusche D; Schaer BA; Osswald S; Sticherling C
    Circulation; 2008 May; 117(21):2727-33. PubMed ID: 18490526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators in children.
    Werner B; Przybylski A; Kucińska B; Lewandowski M; Szwed H; Wróblewska-Kałuzewska M
    Kardiol Pol; 2004 Mar; 60(3):239-46. PubMed ID: 15156219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-lasting survival of patients with implantable cardioverter-defibrillators implanted for secondary preventive reasons].
    Kozák M; Sepsi M; Vlasínová J
    Cas Lek Cesk; 2005; 144(5):309-12; discussion 313-4. PubMed ID: 16013516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.
    Kobza R; Jenni R; Erne P; Oechslin E; Duru F
    Pacing Clin Electrophysiol; 2008 Apr; 31(4):461-7. PubMed ID: 18373765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
    Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ; Schmitt J; Cicek-Hartvig S; Hohnloser SH; Israel CW
    Europace; 2009 Mar; 11(3):297-302. PubMed ID: 19054788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients.
    Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z
    Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.